关注
Swarali S Kulkarni
Swarali S Kulkarni
Tessera Therapeutics
在 tesseratx.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
High potency of a bivalent human VH domain in SARS-CoV-2 animal models
W Li, A Schäfer, SS Kulkarni, X Liu, DR Martinez, C Chen, Z Sun, SR Leist, ...
Cell 183 (2), 429-441. e16, 2020
1222020
Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection
W Li, C Chen, A Drelich, DR Martinez, LE Gralinski, Z Sun, A Schäfer, ...
Proceedings of the National Academy of Sciences 117 (47), 29832-29838, 2020
882020
Unique aspects of adaptive immunity in camelids and their applications
SS Kulkarni, D Falzarano
Molecular Immunology 134, 102-108, 2021
62021
Immune Responses to MERS-CoV in Humans and Animals
NK Alharbi, SS Kulkarni, D Falzarano
Microbial Pathogenesis: Infection and Immunity, 85-97, 2021
22021
Neutralizing antibodies are associated with protection in animal models of coronavirus infection and vaccination.
SS Kulkarni
University of Saskatchewan, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–5